La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Chemed Gestione

Gestione criteri di controllo 3/4

Chemed's Il CEO è Kevin McNamara, nominato in Aug1994, e ha un mandato di 37.58 anni. la retribuzione annua totale è $ 12.63M, composta da 12.7% di stipendio e 87.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.71% delle azioni della società, per un valore di $ 60.93M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 24.3 anni e 15.3 anni.

Informazioni chiave

Kevin McNamara

Amministratore delegato

US$12.6m

Compenso totale

Percentuale dello stipendio del CEO	12.7%
Mandato del CEO	30yrs
Proprietà del CEO	0.7%
Durata media del management	24.3yrs
Durata media del Consiglio di amministrazione	15.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

May 14

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Apr 26

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Mar 01

The Price Is Right For Chemed Corporation (NYSE:CHE)

Dec 30

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Nov 30

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Oct 26

Chemed - Showcasing Why It's So Reliable

Aug 26

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

Aug 13

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Aug 01

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Jul 14

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Jun 07

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Apr 09

Chemed Q4 2022 Earnings Preview

Feb 22

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Feb 14

Is Chemed (NYSE:CHE) Using Too Much Debt?

Jan 05

Here's What Chemed's (NYSE:CHE) Strong Returns On Capital Mean

Dec 17

Chemed declares $0.38 dividend

Nov 04

Chemed Q3 2022 Earnings Preview

Oct 28

Does Chemed (NYSE:CHE) Have A Healthy Balance Sheet?

Oct 01

Capital Investment Trends At Chemed (NYSE:CHE) Look Strong

Sep 16

Buy Chemed To Reduce Equity Beta And Stabilize Portfolio Returns

Aug 26

A Look At The Intrinsic Value Of Chemed Corporation (NYSE:CHE)

Aug 16

Chemed declares $0.38 dividend

Aug 05

Chemed Q2 results mixed, co increases top end of FY 2022 adj. EPS guidance range

Jul 27

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Kevin McNamara rispetto agli utili di Chemed?
Data	Compenso totale	Stipendio	Guadagni aziendali
Jun 30 2024	n/a	n/a	US$301m
Mar 31 2024	n/a	n/a	US$283m
Dec 31 2023	US$13m	US$2m	US$273m
Sep 30 2023	n/a	n/a	US$245m
Jun 30 2023	n/a	n/a	US$226m
Mar 31 2023	n/a	n/a	US$240m
Dec 31 2022	US$12m	US$1m	US$250m
Sep 30 2022	n/a	n/a	US$262m
Jun 30 2022	n/a	n/a	US$277m
Mar 31 2022	n/a	n/a	US$267m
Dec 31 2021	US$12m	US$1m	US$269m
Sep 30 2021	n/a	n/a	US$308m
Jun 30 2021	n/a	n/a	US$303m
Mar 31 2021	n/a	n/a	US$329m
Dec 31 2020	US$12m	US$1m	US$319m
Sep 30 2020	n/a	n/a	US$271m
Jun 30 2020	n/a	n/a	US$263m
Mar 31 2020	n/a	n/a	US$231m
Dec 31 2019	US$10m	US$1m	US$220m
Sep 30 2019	n/a	n/a	US$209m
Jun 30 2019	n/a	n/a	US$201m
Mar 31 2019	n/a	n/a	US$205m
Dec 31 2018	US$9m	US$1m	US$206m
Sep 30 2018	n/a	n/a	US$206m
Jun 30 2018	n/a	n/a	US$190m
Mar 31 2018	n/a	n/a	US$113m
Dec 31 2017	US$8m	US$1m	US$98m

Compensazione vs Mercato: La retribuzione totale di Kevin ($USD 12.63M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 8.39M ).

Compensazione vs guadagni: La retribuzione di Kevin è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Kevin McNamara (70 yo)

30yrs

Mandato

US$12,625,106

Compensazione

Mr. Kevin J. McNamara has been the Chief Executive Officer of Chemed Corporation since May 2001 and has been its President since August 2, 1994. Previously, Mr. McNamara served as an Executive Vice Preside...

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Kevin McNamara	CEO, President & Director	30yrs	US$12.63m	0.71% $ 61.1m
Michael Witzeman	VP, Controller	12.3yrs	US$2.93m	0.025% $ 2.2m
Spencer Lee	Executive Vice President	24.3yrs	US$3.37m	0.13% $ 11.6m
Thomas Hutton	VP & Director	36.5yrs	Nessun dato	0.56% $ 48.4m
Nicholas Westfall	Executive Vice President	8.2yrs	US$4.71m	0.041% $ 3.5m
Lisa Reinhard	VP, Chief Administrative Officer & Secretary	29.8yrs	Nessun dato	Nessun dato
Sherri Warner	Director of Investor Relations	no data	Nessun dato	Nessun dato
Brian Judkins	VP, Secretary & Chief Legal Officer	4yrs	Nessun dato	0.0095% $ 821.0k
Nathan McNamara	VP & Chief Strategy Officer	no data	Nessun dato	Nessun dato

24.3yrs

Durata media

52.5yo

Età media

Gestione esperta: Il team dirigenziale di CHE è esperto e expertise (durata media dell'incarico 24.3 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Kevin McNamara	CEO, President & Director	37.6yrs	US$12.63m	0.71% $ 61.1m
Thomas Hutton	VP & Director	39.6yrs	Nessun dato	0.56% $ 48.4m
Thomas Rice	Independent Director	15.3yrs	US$278.27k	0.040% $ 3.5m
Sandra Laney	Director Emeritus	15.3yrs	US$157.02k	Nessun dato
Patrick Grace	Independent Director	28.6yrs	US$308.60k	0.022% $ 1.9m
George Walsh	Independent Chairman	29.6yrs	US$453.15k	0.027% $ 2.4m
Andrea Lindell	Independent Director	16.3yrs	US$272.77k	0.044% $ 3.8m
Christopher Heaney	Independent Director	4.3yrs	US$279.43k	0.014% $ 1.2m
Ron DeLyons	Independent Director	4.3yrs	US$278.27k	0.0093% $ 802.0k
John Mount	Independent Director	2yrs	US$278.27k	0.0043% $ 376.7k
Eileen McCarthy	Independent Director	1.3yrs	US$238.52k	0.0039% $ 333.4k

15.3yrs

Durata media

70yo

Età media

Consiglio di amministrazione esperto: Il consiglio di amministrazione di CHE è composto da personale esperto e esperto (durata media dell'incarico 15.3 anni).

Chemed Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

VP & Director notifies of intention to sell stock

Executive Vice President recently sold US$1.1m worth of stock

Executive Vice President notifies of intention to sell stock

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

CEO, President & Director recently sold US$2.3m worth of stock

Recent updates

Chemed Remains A Buy On Long-Term Economics

VP & Director notifies of intention to sell stock

Second quarter dividend increased to US$0.50

Chemed Corporation Declares Quarterly Dividend, Payable on August 30, 2024

Executive Vice President recently sold US$1.1m worth of stock

Executive Vice President notifies of intention to sell stock

Second quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation's (NYSE:CHE) Shares May Have Run Too Fast Too Soon

Chemed Corporation to Report Q2, 2024 Results on Jul 24, 2024

CEO, President & Director recently sold US$816k worth of stock

CEO, President & Director notifies of intention to sell stock

First quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on June 18, 2024

Chemed: Growth Does Not Justify The Current Stock Price

CEO, President & Director recently sold US$2.3m worth of stock

Here's Why Chemed Corporation's (NYSE:CHE) CEO Compensation Is The Least Of Shareholders' Concerns

Is Chemed Corporation (NYSE:CHE) Trading At A 50% Discount?

Chemed Corporation Reiterates Earnings Guidance for Full Year 2024

First quarter 2024 earnings: EPS misses analyst expectations

Chemed Corporation, Annual General Meeting, May 20, 2024

New major risk - Revenue and earnings growth

Executive Vice President exercised options and sold US$3.8m worth of stock

Executive Vice President recently sold US$1.3m worth of stock

Chemed Corporation to Report Q1, 2024 Results on Apr 24, 2024

Price target increased by 10% to US$690

Chemed Corporation (NYSE:CHE) Full-Year Results: Here's What Analysts Are Forecasting For This Year

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 22% overvalued after recent price rise

Third quarter dividend of US$0.40 announced

Chemed Corporation Declares Quarterly Dividend, Payable on March 15, 2024

Chemed Corporation to Report Q4, 2023 Results on Feb 27, 2024

The Price Is Right For Chemed Corporation (NYSE:CHE)

Chemed Corporation Appoints Michael D. Witzeman as Chief Financial Officer, Effective January 1, 2024

CEO, President & Director recently sold US$859k worth of stock

Chemed: Continues To Compound Shareholder Value At Double-Digit Returns

Executive Vice President recently sold US$580k worth of stock

Executive VP & CFO notifies of intention to sell stock

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Chemed Corporation Announces the Retirement of David P. Williams as Chief Financial Officer Effective December 31, 2023

Executive VP & CFO exercised options to buy US$5.9m worth of stock.

CEO, President & Director recently sold US$1.7m worth of stock

Chemed Corporation Provides Earnings Guidance for the Full-Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

Chemed Corporation to Report Q3, 2023 Results on Oct 25, 2023

Chemed - Showcasing Why It's So Reliable

Chemed: Still Bullish On Economic Characteristics, But Risks Shouldn't Be Overlooked

CEO, President & Director recently sold US$2.1m worth of stock

Is Chemed Corporation (NYSE:CHE) Worth US$521 Based On Its Intrinsic Value?

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Capital Investments At Chemed (NYSE:CHE) Point To A Promising Future

Chemed Corporation to Report Q2, 2023 Results on Jul 26, 2023

Chemed (NYSE:CHE) Has A Rock Solid Balance Sheet

Executive Vice President notifies of intention to sell stock

Independent Director recently sold US$160k worth of stock

Independent Director notifies of intention to sell stock

CEO, President & Director recently sold US$2.2m worth of stock

CEO, President & Director exercised options and sold US$412k worth of stock

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chemed (NYSE:CHE) Is Aiming To Keep Up Its Impressive Returns

CEO, President & Director recently sold US$1.6m worth of stock

Executive VP & CFO recently sold US$2.1m worth of stock

CEO, President & Director recently sold US$1.0m worth of stock

CEO, President & Director exercised options to buy US$1.2m worth of stock.

Full year 2022 earnings: EPS misses analyst expectations

Chemed Q4 2022 Earnings Preview

Chemed Corporation Declares Quarterly Cash Dividend Payable on March 17, 2023

Chemed Corporation: Long-Term Tailwinds, But Remains A Hold

Chemed Corporation to Report Q4, 2022 Results on Feb 23, 2023